Related references
Note: Only part of the references are listed.Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients
Jung Youn Kim et al.
NEURO-ONCOLOGY (2019)
Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma
Philipp Kickingereder et al.
NEURO-ONCOLOGY (2018)
Imaging biomarker roadmap for cancer studies
James P. B. O'Connor et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma
Michael Ingrisch et al.
INVESTIGATIVE RADIOLOGY (2017)
The Rise of Radiomics and Implications for Oncologic Management
Vivek Verma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
MRI features predict survival and molecular markers in diffuse lower-grade gliomas
Hao Zhou et al.
NEURO-ONCOLOGY (2017)
Local Fractional Anisotropy Is Reduced in Areas with Tumor Recurrence in Glioblastoma
Stefanie Bette et al.
RADIOLOGY (2017)
The Rise of Radiomics and Implications for Oncologic Management
Vivek Verma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Texture Feature Ratios from Relative CBV Maps of Perfusion MRI Are Associated with Patient Survival in Glioblastoma
J. Lee et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response
Philipp Kickingereder et al.
CLINICAL CANCER RESEARCH (2016)
Approaches to Regularized Regression - A Comparison between Gradient Boosting and the Lasso
Tobias Hepp et al.
METHODS OF INFORMATION IN MEDICINE (2016)
Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models
Philipp Kickingereder et al.
RADIOLOGY (2016)
Radiomics: Images Are More than Pictures, They Are Data
Robert J. Gillies et al.
RADIOLOGY (2016)
Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastoma
Philipp Kickingereder et al.
NEURO-ONCOLOGY (2015)
Pseudoprogression in Patients with Glioblastoma: Assessment by Using Volume-weighted Voxel-based Multiparametric Clustering of MR Imaging Data in an Independent Test Set
Ji Eun Park et al.
RADIOLOGY (2015)
Extent of Resection of Glioblastoma Revisited: Personalized Survival Modeling Facilitates More Accurate Survival Prediction and Supports a Maximum-Safe-Resection Approach to Surgery
Nicholas F. Marko et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide
Brian J. Gebhardt et al.
RADIATION ONCOLOGY (2014)
Outcome Prediction in Patients with Glioblastoma by Using Imaging, Clinical, and Genomic Biomarkers: Focus on the Nonenhancing Component of the Tumor
Rajan Jain et al.
RADIOLOGY (2014)
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
Hugo J. W. L. Aerts et al.
NATURE COMMUNICATIONS (2014)
Statistical normalization techniques for magnetic resonance imaging
Russell T. Shinohara et al.
NEUROIMAGE-CLINICAL (2014)
Diffusion tensor invasive phenotypes can predict progression-free survival in glioblastomas
L. A. Mohsen et al.
BRITISH JOURNAL OF NEUROSURGERY (2013)
Genomic Mapping and Survival Prediction in Glioblastoma: Molecular Subclassification Strengthened by Hemodynamic Imaging Biomarkers
Rajan Jain et al.
RADIOLOGY (2013)
The Medical Imaging Interaction Toolkit: challenges and advances
Marco Nolden et al.
INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY (2013)
Adult glioblastoma multiforme survival in the temozolomide era: A population-based analysis of Surveillance, Epidemiology, and End Results registries
Amy S. Darefsky et al.
CANCER (2012)
Glioblastoma survival in the United States before and during the temozolomide era
Derek R. Johnson et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Radiomics: the process and the challenges
Virendra Kumar et al.
MAGNETIC RESONANCE IMAGING (2012)
A semiautomatic CT-based ensemble segmentation of lung tumors: Comparison with oncologists' delineations and with the surgical specimen
Emmanuel Rios Velazquez et al.
RADIOTHERAPY AND ONCOLOGY (2012)
PATTERN OF FAILURE AFTER LIMITED MARGIN RADIOTHERAPY AND TEMOZOLOMIDE FOR GLIOBLASTOMA
Mark W. McDonald et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Radiographic patterns of relapse in glioblastoma
Marc C. Chamberlain
JOURNAL OF NEURO-ONCOLOGY (2011)
DTI and PWI analysis of peri-enhancing tumoral brain tissue in patients treated for glioblastoma
Alessandro Stecco et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
A reproducible evaluation of ANTs similarity metric performance in brain image registration
Brian B. Avants et al.
NEUROIMAGE (2011)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Improving target delineation on 4-dimensional CT scans in stage I NSCLC using a deformable registration tool
Iris E. van Dam et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Genome-wide association analysis by lasso penalized logistic regression
Tong Tong Wu et al.
BIOINFORMATICS (2009)
Submissions to Radiology: Our Top 10 List of Statistical Errors
Deborah Levine et al.
RADIOLOGY (2009)
Multiparametric tissue characterization of brain neoplasms and their recurrence using pattern classification of MR images
Ragini Verma et al.
ACADEMIC RADIOLOGY (2008)
Prognostic value of perfusion MR imaging of high-grade astrocytomas: Long-term follow-up study
T. Hirai et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
Apparent diffusion coefficient and cerebral mood volume in brain gliomas: Relation to tumor cell density and tumor microvessel density based on seterotactic biopsies
N. Sadeghi et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme
Karla V. Ballman et al.
NEURO-ONCOLOGY (2007)
Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data
J Gui et al.
BIOINFORMATICS (2005)
Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults
AT Parsa et al.
JOURNAL OF NEUROSURGERY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Survival analysis in patients with glioblastoma multiforme: Predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume
J Oh et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2004)
Influence of MRI acquisition protocols and image intensity normalization methods on texture classification
G Collewet et al.
MAGNETIC RESONANCE IMAGING (2004)
Share Paper
